2018 Adult Prevalence Tables
Table 8: Estimated percent using inhaled short acting beta agonists among adults 1 with current 2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2018.
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 166 | 52.6 | 7.1 | (38.7 – 66.5) |
| California | 221 | 45.7 | 4.7 | (36.5 – 54.9) |
| Connecticut | 283 | 49.2 | 4.6 | (40.2 – 58.2) |
| Florida | 461 | 38.9 | 4.5 | (30.1 – 47.7) |
| Georgia | 147 | 40.8 | 5.1 | (30.8 – 50.8) |
| Hawaii | 217 | 40.5 | 5.0 | (30.7 – 50.3) |
| Illinois | 155 | 46.8 | 5.2 | (36.6 – 57.0) |
| Indiana | 182 | 48.8 | 5.3 | (38.4 – 59.2) |
| Iowa | 249 | 56.0 | 3.9 | (48.4 – 63.6) |
| Kansas | 280 | 55.7 | 4.3 | (47.3 – 64.1) |
| Maine | 476 | 58.2 | 4.3 | (49.8 – 66.6) |
| Maryland | 297 | 45.6 | 4.6 | (36.6 – 54.6) |
| Massachusetts | 180 | 46.4 | 6.0 | (34.6 – 58.2) |
| Michigan | 480 | 59.7 | 3.1 | (53.6 – 65.8) |
| Minnesota | 560 | 44.6 | 2.6 | (39.5 – 49.7) |
| Missouri | 186 | 60.5 | 5.3 | (50.1 – 70.9) |
| Montana | 151 | 45.3 | 5.5 | (34.5 – 56.1) |
| Nebraska | 412 | 45.5 | 4.0 | (37.7 – 53.3) |
| Nevada | 99 | 61.7 | 6.8 | (48.4 – 75.0) |
| New Hampshire | 180 | 58.0 | 6.0 | (46.2 – 69.8) |
| New Mexico | 204 | 55.7 | 5.0 | (45.9 – 65.5) |
| New York | 313 | 57.6 | 5.3 | (47.2 – 68.0) |
| Ohio | 400 | 53.4 | 4.1 | (45.4 – 61.4) |
| Oregon | 238 | 59.5 | 4.5 | (50.7 – 68.3) |
| Pennsylvania | 206 | 52.4 | 5.0 | (42.6 – 62.2) |
| Rhode Island | 181 | 50.1 | 5.4 | (39.5 – 60.7) |
| Texas | 207 | 56.0 | 9.1 | (38.2 – 73.8) |
| Utah | 342 | 55.4 | 3.5 | (48.5 – 62.3) |
| Vermont | 226 | 52.2 | 4.9 | (42.6 – 61.8) |
| Wisconsin | 206 | 60.8 | 5.5 | (50.0 – 71.6) |
| Puerto Rico | 202 | 32.7 | 4.5 | (23.9 – 41.5) |
| 31 States / Area | 8,107 | 50.7 | 1.4 | (48.0 – 53.4) |
| Median | 52.4 | |||
| Range | 32.7-61.7 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2018/pdf/sdq_report_acbs_18-508.pdfpdf icon
Page last reviewed: October 8, 2021